These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 39133439)

  • 1. Tertiary lymphoid structures and their therapeutic implications in cancer.
    Chen X; Wu P; Liu Z; Li T; Wu J; Zeng Z; Guo W; Xiong W
    Cell Oncol (Dordr); 2024 Oct; 47(5):1579-1592. PubMed ID: 39133439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary lymphoid structures in cancer.
    Schumacher TN; Thommen DS
    Science; 2022 Jan; 375(6576):eabf9419. PubMed ID: 34990248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tertiary lymphoid structures: new immunotherapy biomarker.
    Yang F; Yang J; Wu M; Chen C; Chu X
    Front Immunol; 2024; 15():1394505. PubMed ID: 39026662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
    Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
    J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis.
    Zhang X; Yao J; Xie M; Liang Y; Lin X; Song J; Bao X; Ma X; Wang Y; Zhang Y; Liu Y; Han W; Pan L; Xue X
    Int Immunopharmacol; 2024 Oct; 140():112790. PubMed ID: 39088920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.
    Zhao L; Jin S; Wang S; Zhang Z; Wang X; Chen Z; Wang X; Huang S; Zhang D; Wu H
    Signal Transduct Target Ther; 2024 Aug; 9(1):225. PubMed ID: 39198425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary lymphoid structures and cytokines interconnections: The implication in cancer immunotherapy.
    Li H; Ding JY; Zhang MJ; Yu HJ; Sun ZJ
    Cancer Lett; 2023 Aug; 568():216293. PubMed ID: 37392991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
    Chen J; Chen J; Wang L
    J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer.
    Weng Y; Yuan J; Cui X; Wang J; Chen H; Xu L; Chen X; Peng M; Song Q
    Sci Rep; 2024 Jul; 14(1):16246. PubMed ID: 39009684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte homing and recirculation with tumor tertiary lymphoid structure formation: predictions for successful cancer immunotherapy.
    Tian W; Wei W; Qin G; Bao X; Tong X; Zhou M; Xue Y; Zhang Y; Shao Q
    Front Immunol; 2024; 15():1403578. PubMed ID: 39076974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
    Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X
    Front Immunol; 2023; 14():1222719. PubMed ID: 37529035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral CXCL13
    Wang J; Liang Y; Xue A; Xiao J; Zhao X; Cao S; Li P; Dong J; Li Y; Xu Z; Yang L
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39244216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A
    Zhang D; Jiang D; Jiang L; Ma J; Wang X; Xu X; Chen Z; Jiang M; Ye W; Wang J; Meng W; Qiu W; Hou Y; Huang J; Jiao Y; Liu Y; Liu Z
    Br J Cancer; 2024 Jul; 131(1):184-195. PubMed ID: 38762674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies.
    Kang W; Feng Z; Luo J; He Z; Liu J; Wu J; Rong P
    Front Immunol; 2021; 12():689270. PubMed ID: 34394083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice.
    Delvecchio FR; Fincham REA; Spear S; Clear A; Roy-Luzarraga M; Balkwill FR; Gribben JG; Bombardieri M; Hodivala-Dilke K; Capasso M; Kocher HM
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1543-1565. PubMed ID: 34252585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study.
    Wang YQ; Chen WJ; Zhou W; Dong KQ; Zuo L; Xu D; Chen JX; Chen WJ; Li WY; Liu ZC; Jiang ZY; Tang YF; Qin YX; Wang LH; Pan XW; Cui XG
    J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38908856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
    Shen C; Zhang DL; Cheng XL; Zhang WC; Zhao JJ
    Urol Int; 2023; 107(9):841-847. PubMed ID: 37769625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses].
    Fridman WH; Petitprez F; Sautes-Fridman C
    Bull Cancer; 2020 Apr; 107(4):403-404. PubMed ID: 32284150
    [No Abstract]   [Full Text] [Related]  

  • 20. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response.
    Zhang Q; Wu S
    Front Immunol; 2022; 13():1063711. PubMed ID: 36713409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.